pharmacoeconomic moh program 1

Norah Al JohanyHead of Pharmacoeconomic department General administration of pharmaceutical carenoaljohany@moh.gov.sa

Pharmacoeconomic PROGRAM 1

70Pharmacists

4 Pharmacists

Pharmacoeconomic Analysis of DPIC InquiriesLevel ($) Description ($) Cost 95% CI

0 No medication-related problems 0 NA

1 No change in therapy or no harm 0 NA

2 Physician visit 64.50 NA

3a Additional tests 95.00 73-116

3b Non-invasive procedure 184.00 120-248

4a Additional treatment 227.00 147-306

4b Additional treatment/ non-invasive procedure 411.00 267-554

4c Increased length of stay/ invasive procedure 2505.00 1569-3441

4d Increased length of stay 2598.00 1471-3722

5a Transfer to ICU 2640.00 1471-3808

5b Transfer to ICU/invasive procedure 5145.00 3040-7249

5c Long-term care admission 4571.47 NA

6 Death 100,000.00 NA

Example

• Dr prescribe Denosumab for my 50 y old mother I want complete drug information

• If I did not answer the question what will happen ?

• The use of dentinox for my 1 w y old doter

Total Cost Saving = 139155 $ / one month

Pharmacists intervention cost

Part 2

• Saudi Arabian healthcare budget seen to surge 74% with (4.550.000.000) billion riyals approved amount budget for medicines and medical supplies

• So we have to Respond to society’s question: “Are we receiving the greatest benefit for our health care riyals?”

• With the Growing number of alternatives Need for efficiency and Rising health care cost

Need for Pharmacoeconomic in the ministry of health

Ministry of healthKingdom of Saudi ArabiaPharmacoeconomic Manual

Formulary management • Clinical decisions – drug selection at patient level• Drug policy • MOH Program management • Resource allocation • Purchase negotiation

Decisions supported by pharmacoeconomic studies

•It is the policy of the Pharmacoeconomic center to do intensive analysis, for all new drug need to be add on the formulary and having evidence for using reported pharmacoeconomics data to improve medication use process and reduce cost rate properly

•It is the policy of the Pharmacoeconomic center to calculate Calculation the cost benefit for MOH program

Policy

•Filling the Pharmacoeconomic MOH Forms for DUE•Pharmacoeconomic Literature Evaluation •Quality of life measuring tool•Assessment tool of medication compliance and persistence)•calculation adverse drug reaction •Calculation the cost benefit for MOH program

Procedures

•To change the misunderstanding of of the Pharmacoeconomic concepts in the ministry of health (NOT DIRECT PRICE) •Cost does not equal the price of a product

Ministry of health Pharmacoeconomic Principles

Decisions makers pharmacist and healthcare provider in the MOH must understand • The Criteria for evaluating pharmaceuticals are safety +efficacy +value • Pharmacoeconomic analysis includes all costs associated with an intervention• How to use the Pharmacoeconomic tools in Decision making

Goal

•It is the policy of the Pharmacoeconomic center to provide training and service programs to enhance the application of economic and effectiveness measures to the practice of health care and the management of health systems

Policy

Part 3

•Purpose ?•How

Ministry of health Pharmacoeconomic Research

Drug Related Problems Program forms to calculate the cost of Medication Errors Adverse drug reaction

Filling Pharmacoeconomic MOH data collection forms

•DPIC Inquiries Program•Drug evaluation scoring•Pharmacist intervention cost of avoidance

Cost analysis

Part 4

•Participates in Conferences and exhibitions and forums•Subscriptions books and scientific journals and special pharmacoeconomic educational materials

Establishes Pharmacoeconomic specialist pharmacist program